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804-3 Quality of Life of Patients With Symptomatic Multivessel 
Coronary Disease: The Medicine, Angiopleety, or 
Surgery Study (MASS II) 
Dircau Carrara. Shidey B. Hiscock, Elisabete S. Margarido, Alice Tanaka, Mmydhes E. 
Takiuti, Desiderio Favarato, Protasio L Luz, Whedy Hueb. Sergio A. Olveira, Jose A. 
Ramires, Heart Institute-University of Sao Paulo-Brazil, Sao Paulo, Brazil. 
Background: although coronary angioplasty (PTCA) and coronary bypass surgery 
(CABG) are routinely used, there is no conclusive evidence that these interventional 
methods offer greater benefit than medical therapy MT alone as far as quality of life 
(QOL). 
Objective: This study sought o evaluate the QOL of three possible therapeutic strategies 
for patients with symptomatic multivessel coronary disease and preserved ventricular 
function. 
Methods: a total of 7783 eligible patients with multivessel disease were screened in a 
single institution and 611 (7.8%) patients were randomly assigned to undergo CAGB, 
(203) to PTCA (205) and (203) to MT. QOL was evaluated by SF-36 questionnaire by 
interviews, in the pre treatment phase and 6 and 12 months of follow up. 
Results: although all treatments offered improvement in QOL, such amelioration was 
greater in surgical group(table). *p<.0001 
Conclusion: in conclusion surgical treatment offers better QOL among patients with 
extensive CAD than PCTA or MT. 
TREATMENT ANGIOPLASTY CLINICAL SURGERY 
PERIOD PRE 12mo PRE 12mo PRE 12mo 
Physical Functioning 59.2 72.8* 50.2 66.2* 46.6 73.5* 
Role Physical 34 52.6* 23.4 39.8* 20,7 48.2* 
General Health 64.5 63.8 63.4 60.8 62.5 64.4* 
Mental Health 65.9 74.6* 63.4 70.4* 64.4 74* 
Vitality 64 72.2* 55.6 61.6" 56.1 73.8* 
Role Emotional 51.9 67.1" 49.8 64.9* 45.5 68.9* 
Social Functioning 57.5 70* 57.4 62.7* 52.7 66.9* 
Bobly Pain 63.1 75.4* 61.7 70.1" 56.8 76.8* 
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804-4 Predictors of Stroke After Conventional Versus 
Coronary Revascularization Without Cerdlopulmonary 
Bypass 
Sotiris C. Stamou. Albert J. Pflster, Kathleen A, Jablonski, Peter C. Hill, Mercedes K. 
Dullum, Ammar S. Bail, Steven W. Boyce, Kathleen Petro, Paul J. Corse, Washington 
Hospital Center, Washington, Dist. of Columbia, MedStar Research Institute, 
Washington, Dist. of Columbia. 
BACKGROUND: Postoperative stroke is a serious complication after standard coronary 
artery bypass grafting (CABG) with cardiepulmonary bypass (On-pump). It is unknown 
whether an off-cardiopulmonary b pass approach (OPCAB) may yield a lower stroke rate 
over the conventional On-pump CABG, 
METHODS: From June 1996 to December 2000, OPCAB was performed in 2,430 
patients and compared with 
a contemporaneous computer-matched control of 9,046 patients who had On-pump- 
CABG, during the same peded of time. Patients were matched for age category, number 
of grafted vessels, left venthcular dysfunction, gender, year of surgery, and reoperative 
CABG. Preoperative risk factors for stroke not used in the matching were included in the 
model. The general estimating method was used in a logistic regression to test the differ- 
ence in the post-operative stroke rate between OPCAB and on-pump surgery controlling 
for the correlation between matched sets. 
RESULTS: Matches by propensity score were found for 72% of the OPCAB cases. On- 
pump CABG was associated with a higher incidence of stroke than OPCAB (Table). 
Other independent predictors of stroke are presented in table. 
CONCLUSION: A substantially lower stroke rate suggests that OPCAB is a safe treat- 
ment option for revasoularization. Prospective randomised trials are warranted to confirm 
the results of this study. 
Independent Correlates of Stroke After CABG 
(multivariate logistic regression analysis) 
Risk factors Odds Ratio 95% Confidence P-value 
Intervals 
Ejection fraction < 25% 1.94 1.16 - 3.16 0.009 
Carotid artery disease 1.82 1.00 - 3.10 0.039 
Cardiopulmonary bypass 1.72 1.09 - 281 0.024 
COPD 1.64 1.04 - 2.50 0.025 
Hypertension 1.53 1.12 - 2.13 0.01 
Previous cerebrovascular ccident 1.52 1.00 - 2.28 0.05 
Female gender 1.35 1.01 - 1.78 0.039 
Age 1.04 1.02 - 1.05 <0.001 
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804-5 Use of Both Internal Mammary Arteries for Coronary 
Artery Bypass Grafting in Diabetics Avoiding Median 
Sternotomy 
Vassilios Gulielmos, Utz Kappert, Jens Schneider, Romuald Cichon, Joachim Nicolai, 
Anne Diegeler, Heart Center Dresden, University Hospital, Dresden, German~ 
Background: The use of bilateral internal mammary artery (BIMA) grafting is related to 
increased sternal wound complications. Recent minimally invasive techniques avoiding 
sternotomy with BIMA grafting could hardly be achieved. The introduction of a wrist- 
enhanced robotio system allows the application of BIMA without sternotomy via three 
one cm stab wounds and a small left lateral chest incision allows complete arterial revas- 
cularization using regular cardiopulmonary b pass. 
Methods: Since 5/99 48 patients (35 male. 13 female, aged 65+ 8.5 years, LVEF 67+ 
10.7%) were treated for coronary artery disease. 72% were diabetics. Both IMAs were 
harvested via three ports using the da VincP t surgical system. Access to the heart for 
central aortic cannulation and coronary anastomoses was achieved via a 6 to 8 cm left 
lateral chest incision at the level of the 2nd intercostal space. 
Results: There occurred one death in this series due to pneumonia on postoperative day 
16. Conversion rate to median sternotomy was 6.25%. Duration of surgery was 237.5+ 
74.5 min, ICU stay 22~ 19.1 h. ventilation time 4.3± 10.9 h and total hospital stay 7± 1 
days, respectively. 
Conclusion: The concept of total arterial revascularization using BIMA grafting was 
applied in 72.9%. There were no sternal instabilities or wound infections. This minimally 
invasive approach allows total endoscopic BIMA harvesting using three one cm ports 
only. Via a small left lateral chest incision use of BIMA for CABG is possible. Thus, the 
risk in developing sternal wound complications in diabetics is decreased. 
POSTER SESS ION 
1099 Fundamentals of Myocardial Ischemia 
Monday, March 18, 2002, Noon-2:00 p.m. 
Georgia World Congress Center, Hall G 
Presentation Hour: 1:00 p.m.-2:00 p.m. 
1099-27 Cardioprotection Caused by Ischemic Preconditioning 
or by an Alpha 1-Adrenergic Receptor Agoniat Is 
Blocked in Hearts From Epsilon Protein Kinase C 
Knockout Mice 
Hui-zhono Zhou. Joel S. Karliner, Peili Zhu, Daria Mochly-Rosen, Robert O. Messing, 
Mary O. Gray, VA Medical Center, UCSF, San Francisco, Cafifornia, Stanford University 
San Francisco, California. 
Background: Independent laboratories have shown that Epsilon Protein Kinase C (e- 
PKC) activation is a critical event in cardiac protection induced by ischemic precondition- 
ing. However, cardioprotactive mechanisms have not been thoroughly elucidated. In the 
present study, we used e-PKC knockout (KO) mice to test the hypothesis that e-PKC is 
required for protection induced by both ischemic preconditioning and by the alpha 1- 
adrenenrgic receptor agnonist Phenylephrine (PE). Methods: We subjected isovolumi- 
cally contracting hearts to 20 min ischemia and 30 min reperfusion on a Langendorff 
apparatus. Following reperfusion, heads were perfused with triphenyltetrazolium chloride 
(Trc) to measure infarction size. Results: Although left ventricular (LV) weights were 
bower in KO hearts (134±7 vs.198±8 mg for WT; n=18, P<0.O5), there were no differ- 
ences in LV developed pressure (LVDP) between the two groups (84±3 vs. 86±3 mmHg 
for W3", n=18, P=NS) or in coronary flow (3.0±0.2 vs. 3.1±0.1 ml/min for WT, n=18, 
P=NS) at baseline. Pretreatment of WT hearts with 2 rain ischemia (TIP) or 20 um PE 
improved LVDP recovery during reperfusion (61±3 and 60±4 vs. 20±4 mmHg for con- 
trols, n=6, p<0.05) and decreased CK release (0.36±0.03 and 0.34±0.03 vs. 0.75±0.04 
U/min.g for controls, n=6 P<0.05). As anticipated, TIP and PE reduced infarction size in 
WT hearts (32±4% and 35±3% vs. 47±3% LV volume for controls, n=6, P<0,05). How- 
ever, TIP and PE did not reduce infarction size in KO heads (41±6% and 43±8% vs. 
49±6 LV volume for controls, n=6, P=NS)despite LVDP recovery did not complete abol- 
ished (33 ±7 and 32 ±7 vs19 mmHg for control, n=6, P=NS). Conclusions: These results 
are compelling evidence that e-PKC activation is a critical signaling event initiated by 
ischemic preconditioning and alpha 1-adrenenrgic receptor stimulation that reduces myo- 
cardial infarction. The observation that increases in LVDP induced by TIP or PE are 
diminished but not abolished in KO heads suggests that mechanisms in addition to 
reduction of infarction contribute to contractile recovery. 
1099-28 A New Development of High Fidelity Canine DNA 
Microarray: Application for the Assessment of Gene 
Expressions of Reversibly or Irreversibly Injured 
Ischemic Myocardium 
Masanori Asakura. Masafumi Kitakaze, Shoji Sanada, Hiroshi Asanuma, Seiji 
Takashima, Tetsuji Minamino, Koichi Node, Hisakazu Ogita, Yoshiro Aseno, Yssunori 
Shintani, Liao Yulin, Masatsugu Hori, Osaka University Graduate School of Medicine, 
Suita, Japan, National Cardiovascular Center, Suita, Japan. 
DNA microarray opens the window to assess molecular consequences following physio- 
logical events. However. commercially available mice DNA micrcarray can not provide 
the precise gene expression profile following different cardiac stress. For example, 
reversible ischemia mediates everal cardiac defense mechanisms uch as development 
